Safety of Intracoronary Infusion of 20 Million C-Kit Positive Human Cardiac Stem Cells in Pigs

BACKGROUND: There is mounting interest in using c-kit positive human cardiac stem cells (c-kit(pos) hCSCs) to repair infarcted myocardium in patients with ischemic cardiomyopathy. A recent phase I clinical trial (SCIPIO) has shown that intracoronary infusion of 1 million hCSCs is safe. Higher doses...

Descripción completa

Detalles Bibliográficos
Autores principales: Keith, Matthew C. L., Tang, Xian-Liang, Tokita, Yukichi, Li, Qian-hong, Ghafghazi, Shahab, Moore IV, Joseph, Hong, Kyung U., Elmore, Brandon, Amraotkar, Alok, Ganzel, Brian L., Grubb, Kendra J., Flaherty, Michael P., Hunt, Gregory, Vajravelu, Bathri, Wysoczynski, Marcin, Bolli, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4408046/
https://www.ncbi.nlm.nih.gov/pubmed/25905721
http://dx.doi.org/10.1371/journal.pone.0124227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4408046/
https://www.ncbi.nlm.nih.gov/pubmed/25905721
http://dx.doi.org/10.1371/journal.pone.0124227

Ejemplares similares